Literature DB >> 12607175

Relation between clinical characteristics of Parkinson's disease and cognitive decline.

Joseph J Locascio1, Suzanne Corkin, John H Growdon.   

Abstract

This study examined how cognitive impairments in Parkinson's disease (PD) are related to clinical characteristics such as age at testing, duration of illness, motor impairment, and especially age at disease onset. To address these issues, we administered 14 tests of memory, language, visuospatial, and frontal lobe capacities to 104 PD patients and 60 healthy volunteers of comparable age and education. The participants completed 1-9 test sessions over 1-10 years. Duration of PD was associated with deteriorating performance on most cognitive tests, independent of age-related decline. Severity of motor impairment, indexed by Hoehn and Yahr stages, was positively related to impairment on almost all cognitive tests, holding age and duration constant. For some tests, especially those that were motorically demanding and those that assessed language skills, cognitive deficits appeared earlier in the disease course for late-onset than for early-onset PD patients. These late onset deficits were synergistic effects beyond the additive contributions of disease duration and normal aging. These findings may assist physicians in advising PD patients and their families about the future course of the illness.

Entities:  

Mesh:

Year:  2003        PMID: 12607175     DOI: 10.1076/jcen.25.1.94.13624

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  26 in total

Review 1.  Gender differences in Parkinson's disease: clinical characteristics and cognition.

Authors:  Ivy N Miller; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

Review 2.  Implicit learning in aging: extant patterns and new directions.

Authors:  Anna Rieckmann; Lars Bäckman
Journal:  Neuropsychol Rev       Date:  2009-10-09       Impact factor: 7.444

Review 3.  MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Authors:  Irene Litvan; Dag Aarsland; Charles H Adler; Jennifer G Goldman; Jaime Kulisevsky; Brit Mollenhauer; Maria C Rodriguez-Oroz; Alexander I Tröster; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

4.  Diagnostic test systematic reviews: bibliographic search filters ("Clinical Queries") for diagnostic accuracy studies perform well.

Authors:  Monika Kastner; Nancy L Wilczynski; Ann K McKibbon; Amit X Garg; R Brian Haynes
Journal:  J Clin Epidemiol       Date:  2009-02-20       Impact factor: 6.437

5.  Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.

Authors:  Stephen N Gomperts; Joseph J Locascio; Dorene Rentz; Andrea Santarlasci; Marta Marquie; Keith A Johnson; John H Growdon
Journal:  Neurology       Date:  2012-12-12       Impact factor: 9.910

6.  Paired-pulse inhibition in the auditory cortex in Parkinson's disease and its dependence on clinical characteristics of the patients.

Authors:  Elena Lukhanina; Natalia Berezetskaya; Irina Karaban
Journal:  Parkinsons Dis       Date:  2010-11-01

7.  New MRI Biomarkers Advance the Characterization of Parkinson Disease.

Authors:  David A Ziegler; Suzanne Corkin
Journal:  Eur Neurol Rev       Date:  2013

8.  Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease.

Authors:  Erin R Foster; Kevin J Black; Jo Ann V Antenor-Dorsey; Joel S Perlmutter; Tamara Hershey
Journal:  Brain Cogn       Date:  2007-11-19       Impact factor: 2.310

9.  Motor impulsivity in Parkinson disease: associations with COMT and DRD2 polymorphisms.

Authors:  David A Ziegler; Paymon Ashourian; Julien S Wonderlick; Alison K Sarokhan; Drazen Prelec; Clemens R Scherzer; Suzanne Corkin
Journal:  Scand J Psychol       Date:  2014-04-21

Review 10.  Imaging the role of amyloid in PD dementia and dementia with Lewy bodies.

Authors:  Stephen N Gomperts
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.